Itoyama M - Search Results

1

A Rare Case of Adult Poorly Differentiated Chordoma of the Skull Base With Rapid Progression and Systemic Metastasis: A Review of the Literature.

Harada K, Shinojima N, Yamamoto H, Itoyama M, Uchida D, Dekita Y, Miyamaru S, Uetani H, Orita Y, Mikami Y, Nosaka K, Hirai T, Mukasa A. Harada K, et al. Among authors: itoyama m. Cureus. 2024 Jan 3;16(1):e51605. doi: 10.7759/cureus.51605. eCollection 2024 Jan. Cureus. 2024. PMID: 38173946 Free PMC article.

2

An autopsy case of pulmonary tumor thrombotic microangiopathy that developed during chemotherapy for salivary duct carcinoma of the parotid gland.

Itoyama M, Ohara A, Yokoyama K, Yamamoto S, Kato K, Tada Y, Sugitani A, Sugino H, Yatabe Y, Kusumoto M, Nakamura K, Honma Y. Itoyama M, et al. Auris Nasus Larynx. 2024 Oct;51(5):829-833. doi: 10.1016/j.anl.2024.07.002. Epub 2024 Jul 23. Auris Nasus Larynx. 2024. PMID: 39047424

3

Relationship Between Short-Term Outcomes and PD-L1 Expression Based on Combined Positive Score and Tumor Proportion Score in Recurrent or Metastatic Head and Neck Cancers Treated With Anti-PD-1 Antibody Monotherapy.

Ohara A, Mori T, Itoyama M, Yokoyama K, Yamamoto S, Kato K, Honma Y. Ohara A, et al. Among authors: itoyama m. Cancer Rep (Hoboken). 2025 Jan;8(1):e70125. doi: 10.1002/cnr2.70125. Cancer Rep (Hoboken). 2025. PMID: 39840665 Free PMC article.

4

Transnasal photoimmunotherapy with cetuximab sarotalocan sodium: Outcomes on the local recurrence of nasopharyngeal squamous cell carcinoma.

Omura G, Honma Y, Matsumoto Y, Shinozaki T, Itoyama M, Eguchi K, Sakai T, Yokoyama K, Watanabe T, Ohara A, Kato K, Yoshimoto S. Omura G, et al. Among authors: itoyama m. Auris Nasus Larynx. 2023 Aug;50(4):641-645. doi: 10.1016/j.anl.2022.06.004. Epub 2022 Jun 29. Auris Nasus Larynx. 2023. PMID: 35779979

5

Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin.

Kadono T, Yamamoto S, Hirose T, Ikeda G, Ohara A, Itoyama M, Yokoyama K, Honma Y, Hashimoto T, Sekine S, Ishiyama K, Oguma J, Daiko H, Kato K. Kadono T, et al. Among authors: itoyama m. Esophagus. 2023 Jan;20(1):109-115. doi: 10.1007/s10388-022-00951-4. Epub 2022 Sep 1. Esophagus. 2023. PMID: 36050607 Free PMC article.

6

The cortical high-flow sign in oligodendroglioma, IDH-mutant and 1p/19q-codeleted is correlated with histological cortical vascular density.

Yamashita K, Murayama R, Itoyama M, Kikuchi K, Kusunoki M, Kuga D, Hatae R, Fujioka Y, Otsuji R, Fujita N, Yoshimoto K, Ishigami K, Togao O. Yamashita K, et al. Among authors: itoyama m. Neuroradiology. 2025 Jan 20. doi: 10.1007/s00234-024-03538-1. Online ahead of print. Neuroradiology. 2025. PMID: 39831960

7

Value of gadoxetic acid-enhanced MR imaging for preoperative prediction of future liver regeneration after hemihepatectomy.

Fujita N, Ushijima Y, Itoyama M, Okamoto D, Ishimatsu K, Tabata K, Itoh S, Ishigami K. Fujita N, et al. Among authors: itoyama m. Jpn J Radiol. 2024 Dec;42(12):1439-1447. doi: 10.1007/s11604-024-01629-w. Epub 2024 Aug 16. Jpn J Radiol. 2024. PMID: 39150642 Free PMC article.

8

Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma: Comparison of 240 mg Versus 480 mg Doses.

Murashima Y, Yamamoto S, Hirose T, Kadono T, Ikeda G, Ohara A, Itoyama M, Yokoyama K, Honma Y, Ishiyama K, Oguma J, Daiko H, Kato K. Murashima Y, et al. Among authors: itoyama m. J Gastrointest Cancer. 2024 Sep;55(3):1345-1351. doi: 10.1007/s12029-024-01092-w. Epub 2024 Jul 15. J Gastrointest Cancer. 2024. PMID: 39007963 Free PMC article.

9

Correction to: Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI.

Fujita N, Ushijima Y, Ishimatsu K, Okamoto D, Wada N, Takao S, Murayama R, Itoyama M, Harada N, Maehara J, Oda Y, Ishigami K, Nishie A. Fujita N, et al. Among authors: itoyama m. Abdom Radiol (NY). 2024 Jul;49(7):2559-2560. doi: 10.1007/s00261-024-04466-7. Abdom Radiol (NY). 2024. PMID: 38913139 No abstract available.

10

Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI.

Fujita N, Ushijima Y, Ishimatsu K, Okamoto D, Wada N, Takao S, Murayama R, Itoyama M, Harada N, Maehara J, Oda Y, Ishigami K, Nishie A. Fujita N, et al. Among authors: itoyama m. Abdom Radiol (NY). 2024 May;49(5):1467-1478. doi: 10.1007/s00261-023-04179-3. Epub 2024 Feb 15. Abdom Radiol (NY). 2024. PMID: 38360959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters